Yesterday, the CFO of Cerus Corp (CERS), Kevin Dennis Green, sold shares of CERS for $65.4K.
Following Kevin Dennis Green’s last CERS Sell transaction on December 11, 2018, the stock climbed by 0.7%.
See today’s analyst top recommended stocks >>
Based on Cerus Corp’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $20.24 million and GAAP net loss of $16.21 million. In comparison, last year the company earned revenue of $18.62 million and had a GAAP net loss of $11.49 million. Currently, Cerus Corp has an average volume of 935.1K. The Company has a Price to Book ratio of 10.1686.
The insider sentiment on Cerus Corp has been positive according to 36 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The company produces blood system for platelets and plasma. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
